Formuepleje A/S’s Idexx Laboratories IDXX Stock Holding History

Formuepleje A/S’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Buy	+1,855	New	+$1.04M	0.08%	88

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Formuepleje A/S's IDXX Position: Q2 2026 in Review

Formuepleje A/S opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 1,855 shares worth $977K. The stake represents 0.08% of the portfolio and ranks #88 among its holdings.

1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Formuepleje A/S held 1,855 shares of Idexx Laboratories worth $977K as of Q2 2026.
Idexx Laboratories was a new Formuepleje A/S position in Q2 2026.
Idexx Laboratories made up 0.08% of Formuepleje A/S's portfolio in Q2 2026, its #88 holding.
1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Formuepleje A/S's 13F filing for Q2 2026, filed 27 Aug 2026.